At Rep. Carter's Urging, FTC Chair Acknowledges Dangers of PBMs
April 28, 2022
April 28, 2022
WASHINGTON, April 28 -- Rep. Buddy Carter, R-Georgia, issued the following news release:
Since day one in Congress, Rep. Earl L. "Buddy" Carter (R-GA) has been sounding the alarm on the predatory practices of the pharmaceutical industry's middlemen, pharmacy benefit managers (PBMs).
Following Rep. Carter's March, 2022 call with Federal Trade Commission (FTC) Chair Lina Khan, she publicly agreed that PBMs reduce patient's access to life-saving dr . . .
Since day one in Congress, Rep. Earl L. "Buddy" Carter (R-GA) has been sounding the alarm on the predatory practices of the pharmaceutical industry's middlemen, pharmacy benefit managers (PBMs).
Following Rep. Carter's March, 2022 call with Federal Trade Commission (FTC) Chair Lina Khan, she publicly agreed that PBMs reduce patient's access to life-saving dr . . .